Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer

BACKGROUND: Sunitinib plays an important role in managing the metastatic renal cell cancer (mRCC). Sunitinib-induced hypothyroidism is a common side-effect of the drug. There have been attempts to link hypothyroidism with a better clinical outcome in sunitinib-treated (mRCC) patients. Our aim was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasileiadis, Theofanis, Chrisofos, Michail, Safioleas, Michail, Kontzoglou, Konstantinos, Papazisis, Konstantinos, Sdrolia, Athina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492389/
https://www.ncbi.nlm.nih.gov/pubmed/31039771
http://dx.doi.org/10.1186/s12885-019-5610-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492389/
https://www.ncbi.nlm.nih.gov/pubmed/31039771
http://dx.doi.org/10.1186/s12885-019-5610-8

Ejemplares similares